African Journal of
Biochemistry Research

  • Abbreviation: Afr. J. Biochem. Res.
  • Language: English
  • ISSN: 1996-0778
  • DOI: 10.5897/AJBR
  • Start Year: 2007
  • Published Articles: 399

Review

Glycated proteins: Clinical utility and analytical approaches

Yoseph Cherinet Megerssa
  • Yoseph Cherinet Megerssa
  • Department of Biomedical Sciences, College of Veterinary Medicine and Agriculture, Addis Ababa University, Ethiopia
  • Google Scholar
Demo Yemane Tesfaye
  • Demo Yemane Tesfaye
  • Department of Medical Laboratory Science, College of Medicine and Health Sciences, Hawassa University, Ethiopia
  • Google Scholar


  •  Received: 18 September 2014
  •  Accepted: 30 January 2015
  •  Published: 28 February 2015

References

Amore A, Cirina P, Conti G, Cerutti F, Bagheri N, Emancipator SN, Coppo R (2004). Amadori-configurated albumin induces nitric oxide-dependent apoptosis of endothelial cells: a possible mechanism of diabetic vasculo pathy. Nephrol Dial Transplant.19:53-60.
Crossref

 

Ansell B, Fonarow G, Navab M, Fogelman A (2007). Modifying the anti-inflammatory effects of high-density Lipoprotein. Curr. Ather. Rep. 9:57-63.
Crossref

 

 

Benjamin R, Sacks D (1994). Glycated protein update: implication of recent studies including the diabetic control and complication trial. Clin. Chem. 40(5):683-687.

 

 

Brown B, Rashid I, Reyk D, Davies M (2007). Glycation of low-density lipoprotein results in the time-dependent accumulation of cholesteryl esters and apolipoprotein B-100 protein in primary human monocyte-derived macrophages. Fed. Euro. Biochem. Soc. J. 274:1530-1541

 

 

Brutis C, Ashwood E, Bruns C (2006). Tietz text book of Clinical Chemistry and Molecular diagnostics Philadelphia USA 4th ed. pp. 879-886.

 

 

Chandalia H, Krishnswamy P (2002). Glycated hemoglobin. Diabet. Curr. Sci. 83(12):1522-1532.

 

 

Cohen M., Clements R.(1999). Measuring glycated proteins: Clinical and methodological aspects. Diabet. Technol. Ther. 1(1):57-70.
Crossref

 

 

Deric M, Stokic E, Vuckovic B, Kojic-Damjanov S, Cabarkapa V (2006). Lipids and atherosclerosis. Jugoslov Med. Biochem. 25:325-333
Crossref

 

 

Epinex diagnostics Inc. (2008). Glycated albumin and diabetes monitoring. Corporate Information Series. 2:8-12.

 

 

Galle J, Wanner C (1999). Modification of lipoproteins in uremia: Oxidation, glycation and carbamoylation. Miner Electrol. Metab. 25:263-268
Crossref

 

 

Graier WF, Kostner GM (1997). Glycated low density lipoprotein and atherogenesis. The missing link between diabetes mellitus and hypercholesterolemia. Eur. J. Clin. Invest. 27:457-459.
Crossref

 

 

Hattori Y, Suzuki M, Hattori S, Kasai K (2002). Vascular smooth muscle cell activation by glycated albumin. Hypertension 39:22-28.
Crossref

 

 

Hedrick C, Thorpe S, Fu M, Herper C, Yoo J, Kim S, Wong H, Peters A, Harper C (2000). Glycation impairs high-density lipoprotein function. Diabetologia 43:312-320.
Crossref

 

 

Iberg N, Fluckiger R (1986). Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites. J. Biol. Chem. 261(29):13542-13545.

 

 

Inaba M, Okuno S, Kumeda Y, Yamada S, Imanishi Y, Tabata T, Okamura M, Okada S, Yamakawa T, Ishimura E, Nishizawa Y (2007). Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J. Am. Soc. Nephrol. 18:896-903.
Crossref

 

 

Jeppsson J, Kobold U, Barr J, Finke A, Wieland H, Hoshino T, Miedema K, Mosca A, Mauri P, Paroni R, Thienpont L, Umemoto M, Weykamp C (2002). Approved IFCC reference method for the measurement of HbA1c in human blood. Clinical Chemistry and Laboratory Medicine. 40(1):78-89.
Crossref

 

 

John W (2003). Hemoglobin A1c: Analysis and Standardization, Clinical Chemistry & Laboratory Medicine. 41(9):1199-1212
Crossref

 

 

Johnson RN, Metcalf PA, Baker JR (1983). Fructosamine: A new approach to the estimation of serum glycosyl protein. An index of diabetic control. Clin Chem Acta.127:87-95.
Crossref

 

 

Klonoff D (2000). Serum fructosamine as a screening test for type 2 diabetes. Diabet. Technol. Ther. (4):537-539.

 

 

Kobayashl K, Ogasahara N, Sekoguchl T, Kimura M, Tanluchi K, Matsuoka A (1990). Agarose gel electrophoresis with nitrobluetetrazolium coloration for determination of glycated lipoproteins in serum from diabetic. Clin. Chem. 36(1):65-69.

 

 

Koga M, Murai J, Saito H, Kasayama S (2010). Glycated albumin and glycated hemoglobin are influenced differently by endogenous insulin secretion in patients with type 2 diabetes. Diabet. Care 33:270-272.
Crossref

 

 

Kouzuma T, Uemastu Y, Usami T, Imamura S (2004). Study of glycated amino acid elimination reaction for an improved enzymatic glycated albumin measurement method. Clinica Chimica Acta. 346:135-143.
Crossref

 

 

Kouzuma T, Usami T, Yamakoshi M, Takahashi M, Imamura S (2002). An enzymatic method for the measurement of glycated albumin in biological samples, Clinica Chimica Acta. 324:61-71
Crossref

 

 

Kumeda Y, Inaba M, Shoj S, Ishimura E, Inariba H, Yabes S, Okamura M, Nshizawa Y (2008). Significant correlation of glycated albumin, but not glycated hemoglobin, with arterial stiffening in haemodialysis patients with type 2 diabetes. Clin. Endocrinol. 69:556-561.
Crossref

 

 

Lacinová K, Eckhardt A, Pataridis S, Sedláková P, Mikšík I. (2010). Glycation of proteins: their analysis and physiological aspects, Advances in Molecular Mechanisms and Pharmacology of Diabetic Complications. 17-38, ISBN: 978-81-7895-499-8

 

 

Maillard LC (1912). Action des acides amines sur les Sucres. Compt. Rend. Acad. Sei. (Paris) 154:66-68.

 

 

Megerssa YC, Gebre MW, Birru SK, Goshu AR, Tesfaye DY (2013). Prevalence of undiagnosed diabetes mellitus and its risk factors in selected institutions at Bishoftu Town, East Shoa, Ethiopia. J. Diabet. Metab. S12:008.

 

 

Miller A, Adeli K (2008). Diatery fructose and the metabolic syndrome. Curr. Opin. Gasteroentrol. 24:204-209.
Crossref

 

 

Mula-Abed W, Hanna B (2001). Measurement of serum fructosamine as an index of glycated protein in patients with nephrotic syndrome and with chronic liver diseases bahrain. Med. Bull. 23(4):169-174.

 

 

Nakayama M, Lzumi G, Nemoto Y, Shibata K, Hasegawa T, Numata M, Wang Kengmin, Kawaguchi Y, Hosoya T. (1999). Suppression of Nε-(carboxymethyl) lysine generation by the antioxidant N-acetylcysteine, International Society for Peritoneal Dialysis 19:207-210.

 

 

Nitin S. (2010). HbA1c and factors other than diabetes mellitus affecting it. Singapore Med. J. 51(8):616-622.

 

 

Okumura A, Mitamura Y, Namekata K, Nakamura K, Harada C, Harada T (2007). Glycated albumin induces activation of activator protein-1 in retinal glial cells. J. Ophthalmol. 51:231-243.

 

 

Pu LJ, Lu L, Shen WF, Zhang Q, Zhang RY., Zhang JS., Hu J., Yang ZK., Ding FH., Chen QJ, Shen J, Fang DH, Lou S (2007). Increased serum glycated albumin level is associated with the presence and severity of coronary artery disease in type 2 diabetic patients. Circ. J. 71:1067-1073.
Crossref

 

 

Reddy SA, Sachan A., Srinivasa RP, Mohan A (2012). Clinical applications of glycosylated hemoglobin. J. Clin. Sci. Res.2:22-33.

 

 

Schleicher E, Wieland OH (1986). Kinetic analysis of glycation as a tool for assessing the half-life of proteins. Biochim. Biophys. Acta 875:65-71.

 

 

Schleicher ED, Olgemoller B, Wiedenmann E, Gerbitz ED (1993). Specific glycation of albumin depends on its half-life. Clin. Chem. 39:625-628.

 

 

Scleiche ED, Vogt BW (1990). Standardization of serum fructosamine assays. Clin. Chem. 36:136-139.

 

 

Singh NR, Rondeau P, Hoareau L, Bourdon E (2007). Identification of preferential protein targets for carbonylation in human mature adipocytes treated with native or glycated albumin. Free Rad. Res. 41(10):1078-1088.
Crossref

 

 

Sultanpur C, Kumar D (2010). Comprehensive review on HbA1c in diagnosis of diabetes mellitus. Int. J. Pharmaceut. Sci. Rev. Res. 3(2):119-122

 

 

Tahara Y, Shima K (1995). Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care 18:440-447.
Crossref

 

 

Takahashi S, Uchino H, Shimizu T, Kanazawa A, Tamura Y, Sakai K, Watada H, Hirose T, Kawamori R, Tanaka Y (2007). Comparison of glycated albumin (GA) and glycated hemoglobin (HbA1c) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control. Endocr. J. 54:139-144.
Crossref

 

 

Tanaka A (2001). Assay for glycated lipoproteins in atherosclerosis. Methods in Molecular Medicine 52:105-111

 

 

Tanaka A, Yui K, Tomie N (2006). New assay for glycated lipoproteins by high-performance liquid chromatography, Annals New York academy of Sciences. 811(1):385-394.

 

 

Tesfaye DY, Kinde S, Medhin G, Megerssa YC, Tadewos A, Tadesse E, Shimelis T (2014). Burden of metabolic syndrome among HIV-infected patients in Southern Ethiopia. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 8:102-107.
Crossref

 

 

Veiraia A, Wales P (2005). Hyperglycemia, lipoprotein glycation and vascular disease, Angiology 56:431-438.
Crossref

 

 

Xua Y, Wub X, Liua W, Lin X, Chen J, He R (2002). A convenient assay of glycoserum by nitrobluetetrazolium with iodoacetamide, Clinica Chimica Acta.325:127-131.
Crossref